RxDoctor Payments Data

Jared Huffman, DO

Neuromusculoskeletal Medicine & OMM · San Diego, CANPI 1205444999

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $96 and has fallen 82.2% since, to $17 in 2023. That places this record below the midpoint for neuromusculoskeletal medicine & omm clinicians in CA, where the typical reported total is $204.

$197in general payments, 2019–2025

Across 11 payments — averaging $17.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$33
  • Novo Nordisk$27
  • Amarin Pharma, Inc.$25
  • AstraZeneca$22
  • Lilly USA, LLC$21
  • AbbVie$19
  • plus $50 from 3 others

What the payments were for

  • Food & beverage$197100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$197 in reported general payments places this provider in the 45th percentile of 113 neuromusculoskeletal medicine & omm providers in California.

See all neuromusculoskeletal medicine & omm providers in California

Medicare billing

Part B allowed, 2024
$98,212
Medicare patients
98
Services billed
1,063

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neuromusculoskeletal medicine & omm in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →